Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negoro

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|February 1, 1992
Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II studyM Fukuoka, S Negoro, N Masuda, et al.
Japanese Journal of Clinical Oncology|September 1, 1984
Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patientsF Ogushi, M Fukuoka, M Takada, et al.
FEBS Letters|March 11, 1996
Solubility of artificial proteins with random sequencesI D Prijambada, T Yomo, F Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathyK Kunisada, S Negoro, E Tone, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]M Fukuoka, M Takada, T Kamei, et al.
British Journal of Cancer|April 3, 1999
Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancerK Takeda, S Negoro, S Kudoh, et al.
Chemotherapy|May 4, 1999
Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancerY Tohda, T Iwanaga, M Takada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1991
[High-dose Tegafur (FT) for primary lung cancer: a phase I trial]K Matsui, M Fukuoka, N Masuda, et al.
American Journal of Clinical Oncology|February 1, 1992
Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot studyS Kudoh, M Fukuoka, S Negoro, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Three-year disease-free survivors of small cell lung cancer treated with combination chemotherapy with or without chest irradiationM Fukuoka, N Masuda, K Matsui, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|February 1, 1992
Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II studyM Fukuoka, S Negoro, N Masuda, et al.
Japanese Journal of Clinical Oncology|September 1, 1984
Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patientsF Ogushi, M Fukuoka, M Takada, et al.
FEBS Letters|March 11, 1996
Solubility of artificial proteins with random sequencesI D Prijambada, T Yomo, F Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathyK Kunisada, S Negoro, E Tone, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]M Fukuoka, M Takada, T Kamei, et al.
British Journal of Cancer|April 3, 1999
Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancerK Takeda, S Negoro, S Kudoh, et al.
Chemotherapy|May 4, 1999
Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancerY Tohda, T Iwanaga, M Takada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1991
[High-dose Tegafur (FT) for primary lung cancer: a phase I trial]K Matsui, M Fukuoka, N Masuda, et al.
American Journal of Clinical Oncology|February 1, 1992
Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot studyS Kudoh, M Fukuoka, S Negoro, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Three-year disease-free survivors of small cell lung cancer treated with combination chemotherapy with or without chest irradiationM Fukuoka, N Masuda, K Matsui, et al.
Pageof 20